Gel4Med Inc.
Newton, MA
- UEI
- NNCLMKVMEA83
- CAGE
- 7ASR0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 655 Watertown St, Newton, MA 02460, USA
- Website
- gelformed.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Miami | HT94252311084 | $156,004 |
Similar vendors
About the company
Gel4Med Inc. is a for-profit corporate entity and manufacturer of goods that has been registered in SAM.gov since 2015. It specializes in developing biosynthetic wound care products, particularly antimicrobial dermal matrices designed to promote infection-free wound healing.
Gel4Med Inc. has received several federal grant awards from the National Institutes of Health (NIH) to support research and development of its antimicrobial wound care products. In 2023, it received a $2.2 million Project Grant from the NIH's National Institute of Diabetes and Digestive and Kidney Diseases to evaluate the clinical efficacy, safety, and feasibility of its G4DERM product, a flowable antimicrobial dermal matrix, for treating complex diabetic foot ulcers. This pilot clinical study aims to collect data on wound healing, tissue regeneration, quality of life, and infection risk in patients with treatment-resistant ulcers. Additionally, in 2020, Gel4Med Inc. received a $300,000 Project Grant from the NIH's National Institute of Allergy and Infectious Diseases for developing antifungal dermal templates for wound healing, and a $469,098 Project Grant from the NIH's National Eye Institute for researching the treatment of microbial keratitis and corneal wound healing. These grants demonstrate Gel4Med Inc.'s expertise in developing innovative antimicrobial and wound healing products for various medical applications, funded through partnerships with NIH institutes focused on infectious diseases, diabetes and kidney diseases, and eye health.
Quick answers
Is Gel4Med Inc. registered in SAM.gov?
Yes. Gel4Med Inc.'s SAM.gov registration is active through April 12, 2027.
What is Gel4Med Inc.'s most recent federal award?
Gel4Med Inc.'s most recent federal grant award is Antimicrobial dermal matrices to promote infection free wound closure in DTU-dfus (R44DK137730), from National Institute of Diabetes and Digestive and Kidney Diseases (NIH), on October 1, 2023.
On GovTribe
See Gel4Med Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors